GHK-Cu · DOSSIER

GHK-Cu

Copper Peptide GHK · Glycyl-L-histidyl-L-lysin-Kupfer(II) · Peptide · 3 AS
LEGAL DE · UNCLASSIFIEDEVIDENCE · EARLY CLINICAL STUDIES3 STUDIES
SUMMARY

In clinical studies of topical use, wrinkle depth decreased and skin elasticity improved.

FIG.01 — SIGNAL CHAIN
Gly-His-Lys (GHK) · Cu²⁺ · ~400.9 Da
EVIDENCE LEVELSPROVEN IN HUMANSANIMAL MODELS ONLYMECHANISM ONLYUNPROVEN IN HUMANS
01

What it does in the body

Findings, each with its evidence level — animal data kept visibly apart from what's unproven in humans.

Fewer fine lines

In clinical studies of topical use, wrinkle depth decreased and skin elasticity improved.

PROVEN IN HUMANS
Collagen boost

Boosts collagen production in lab and animal models and acts as an antioxidant.

ANIMAL MODELS ONLY
Better wound healing

Delivers copper and activates growth factors that are linked to faster skin healing.

MECHANISM ONLY
Cream, not injection

Almost all the evidence comes from topical (cream) use; there is little human data on injected, systemic use.

UNPROVEN IN HUMANS
02

Mechanism of action

What GHK-Cu does in the body — step by step.

01

GHK-Cu (glycyl-L-histidyl-L-lysine with a copper(II) complex) is a naturally occurring tripeptide detected in human plasma, saliva and urine.

02

It binds copper ions and transports them into tissue.

03

In vitro and in preclinical models, effects on collagen synthesis, antioxidant enzyme activity and the expression of growth factors (including VEGF, FGF) have been described.

03

Research status

How far along is the evidence?

PRECLINICALEARLY CLINICAL STUDIESCLINICALLY ESTABLISHED
GHK-Cu has been researched particularly in a dermatological context: clinical studies have examined effects on skin elasticity, wrinkle depth and wound healing.
GHK-Cu has been researched particularly in a dermatological context: clinical studies have examined effects on skin elasticity, wrinkle depth and wound healing.
Several smaller clinical studies showed signs of improved skin healing and anti-aging effects with topical application.
The substance is approved as a cosmetic ingredient (INCI: Copper Tripeptide-1) in the EU and is widely used.
Studies of systemic (injectable) use in humans are scarce; the available clinical evidence relates almost exclusively to topical application.
04

Known risks

Without human data, safety statements are limited. What is known:

01
Topical use: generally well tolerated; contact-allergic reactions described in isolated cases
02
Copper accumulation theoretically possible with systemic (non-cosmetic) use
03
No data on systemic long-term safety available
04
Interactions with copper-binding proteins not sufficiently studied
05

Cited studies

Chronological — links lead to the source.

2009
A clinical double-blind study of GHK-Cu peptide in reduction of fine facial lines
PubMed 19587174 →
2012
GHK-Cu may prevent oxidative stress in skin by regulating copper and modifying expression of numerous antioxidant genes
PubMed 22234264 →
2015
Copper peptide GHK-Cu and its skin benefits: a review of clinical and biochemical evidence
PubMed 26403461 →
06

Frequently asked questions

What is GHK-Cu?+

GHK-Cu (glycyl-L-histidyl-L-lysine with a copper(II) complex) is a naturally occurring tripeptide detected in human plasma, saliva and urine.

What type of peptide is GHK-Cu?+

GHK-Cu belongs to the Copper peptide class.

What is GHK-Cu used for?+

In research, GHK-Cu has primarily been investigated in the context of: Skin & hair, Anti-aging, Recovery. These are research findings (evidence: early clinical studies), not proven benefits in humans and not a usage recommendation.

Is GHK-Cu legal in Germany?+

The regulatory status of GHK-Cu in Germany is not clearly classified.

Is GHK-Cu FDA-approved / legal in the US?+

The FDA status of GHK-Cu is not clearly classified.

Is GHK-Cu legal in Canada?+

The regulatory status of GHK-Cu in Canada is not clearly classified.

Where can I buy GHK-Cu?+

Peptica sells nothing and names no sources. GHK-Cu is "unclassified" in Germany; obtaining unapproved substances outside clinical studies is illegal and carries quality and safety risks.

What is the dosage of GHK-Cu?+

Peptica publishes no dosing. There are no approved dosing guidelines for GHK-Cu; figures circulating online stem from animal studies or anecdote, not from validated human protocols. This is not medical advice.

Is GHK-Cu banned in sport (WADA)?+

GHK-Cu is currently not on the WADA Prohibited List.

What are the known risks of GHK-Cu?+

Documented risks include: Topical use: generally well tolerated; contact-allergic reactions described in isolated cases; Copper accumulation theoretically possible with systemic (non-cosmetic) use. This is not a complete safety assessment and not medical advice — see the risks section for the full list.

How well researched is GHK-Cu?+

The evidence is classified as “early clinical studies”. 3 studies are cited on this page.

What is the molecular weight of GHK-Cu?+

GHK-Cu has a molar mass of about 400.9 Da.

Which peptides are related to GHK-Cu?+

Closely related entries: LL-37, SNAP-8, AHK-Cu. A direct side-by-side comparison is available via the compare function.

07

Dossier

Legal · Structure · Sources.

LEGAL STATUS BY REGION
Germanyunclassified

GHK-Cu (Copper Tripeptide-1) is approved as a cosmetic ingredient in the EU and is freely available in cosmetics. It is not approved as a medicine. Cosmetic use is legal; systemic or injectable use as an unapproved medicine is not legal. No WADA ban, no DmMV relevance. This entry refers to topical cosmetic applications.

Legal status varies by country and can change. This is not legal advice.

STRUCTURE & MOLECULE
H₂NGly-His-Lys (GHK) · Cu²COOH
3
AMINO ACIDS
~400.9
MOL. WEIGHT (Da)
Short plasma half-life (roughly minutes to 1–2 hours depending on the source)
HALF-LIFE
SOURCES & EXTERNAL DATABASES

Methodology: Peptica compiles publicly available studies and regulatory information and assigns each statement an evidence level. Not medical advice. No warranty.

RELATED PEPTIDES & FURTHER READING
08

Community notes

Note: These posts are user opinions and not medical advice. Posts containing dosages, therapeutic claims or purchase recommendations are removed. All entries are manually reviewed before publication.
This page is intended solely for factual, scientifically oriented information. No medical advice · no dosage or usage recommendations · no claims of efficacy · no substitute for medical consultation. Peptica sells no substances. Partner links are marked as advertising; Peptica may earn a commission. © 2026 Peptica · Issue 01